Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
Brief ReportBrief Report

Thyroid Hormone Use in the United States, 1997–2016

Michael E. Johansen, Julie P. Marcinek and Jonathan Doo Young Yun
The Journal of the American Board of Family Medicine March 2020, 33 (2) 284-288; DOI: https://doi.org/10.3122/jabfm.2020.02.190159
Michael E. Johansen
the Grant Family Medicine, OhioHealth, Columbus, OH (MEJ, JPM); Heritage College of Osteopathic Medicine, Ohio University, Columbus, OH (MEJ); Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY); Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie P. Marcinek
the Grant Family Medicine, OhioHealth, Columbus, OH (MEJ, JPM); Heritage College of Osteopathic Medicine, Ohio University, Columbus, OH (MEJ); Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY); Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Doo Young Yun
the Grant Family Medicine, OhioHealth, Columbus, OH (MEJ, JPM); Heritage College of Osteopathic Medicine, Ohio University, Columbus, OH (MEJ); Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY); Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (JY).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Top (1a): The figure identifies the proportion of US adults who reported filling a thyroid hormone replacement prescription in a calendar year between 1997 and 2016. Center (1b): Estimated proportion of US adults from 1997 to 1999 and 2014 to 2016 who reported thyroid hormone replacement by age and sex. Estimates were calculated using postprediction average marginal effects after performing the multivariable logistic regression described in the Methods section. Bottom (1c): Predicted proportion of population between 1997 and 2016 that reported thyroid hormone replacement by race/ethnicity, adjusted for age and sex. Error bars represent 95% CIs. Abbreviation: CI, Confidence interval.

  • Figure 2.
    • Download figure
    • Open in new tab
    Figure 2.

    Top Left (2a): Total expenditure from thyroid hormone between 1997 and 2016. Top right (2b): Mean thyroid hormone expenditure per person/year between 1997 and 2016. Pharmaceutical rebates were not included in the calculations. Bottom left (2c): Mean expenditure per person/year by generic, Synthroid/Cytomel, and other brand thyroid hormone between 2004 and 2016. Pharmaceutical rebates were not included in the calculations. Bottom right (2d): Percentage of thyroid hormone users who reported generic, Synthroid/Cytomel, and other brand thyroid hormones between 2004 and 2016. Individuals can be included in multiple categories. All expenditures were adjusted to 2016 US dollars using the Consumer Price Index. Error bars represent 95% CIs. Abbreviation: CI, Confidence interval.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family  Medicine: 33 (2)
The Journal of the American Board of Family Medicine
Vol. 33, Issue 2
March/April 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thyroid Hormone Use in the United States, 1997–2016
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Thyroid Hormone Use in the United States, 1997–2016
Michael E. Johansen, Julie P. Marcinek, Jonathan Doo Young Yun
The Journal of the American Board of Family Medicine Mar 2020, 33 (2) 284-288; DOI: 10.3122/jabfm.2020.02.190159

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thyroid Hormone Use in the United States, 1997–2016
Michael E. Johansen, Julie P. Marcinek, Jonathan Doo Young Yun
The Journal of the American Board of Family Medicine Mar 2020, 33 (2) 284-288; DOI: 10.3122/jabfm.2020.02.190159
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Many Family Medicine Successful Interventions and Clinical Reviews for Common Illnesses
  • Google Scholar

More in this TOC Section

  • Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema of the Small Bowel: A Diagnostic Dilemma
  • Antidepressant Tapering Is Not Routine But Could Be
  • Financial Incentives Are Associated with Lower Likelihood of COVID-19 Vaccination in Northeast Ohio
Show more Brief Report

Similar Articles

Keywords

  • Data Analysis
  • Health Expenditures
  • Health Services Research
  • Hypothyroidism
  • Thyroid Diseases
  • Thyroid Hormones

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2023 American Board of Family Medicine

Powered by HighWire